Related Experiment Video
Updated: May 17, 2025

Evaluation of T Follicular Helper Cells and Germinal Center Response During Influenza A Virus Infection in Mice
Published on: June 27, 2020
Tollip deficiency enhances mitophagy and reduces STING activation in influenza A virus-infected mice
Hamid Reza Nouri1, Niccolette Schaunaman1, Monica Kraft2
1Department of Medicine, National Jewish Health, Denver, CO, United States.
Abstract:
Toll-interacting protein (Tollip) is an intracellular adaptor protein with diverse functions including regulation of autophagy of mitochondria-mitophagy. Tollip deficiency promotes viral infection, but whether mitophagy is involved remains unclear. We sought to determine if mitophagy and associated signaling such as mitochondrial DNA (mtDNA) release and activation of stimulator of interferon genes (STING) contribute to worsened viral infection due to Tollip deficiency. Wild-type and Tollip knockout (KO) C57/BL6 mice were intranasally infected with influenza A virus (IAV), and then treated with or without a STING agonist 2'3'cGAMP for 4 d. PINK1 (an initiator of mitophagy) KO mouse tracheal epithelial cells (mTECs) or PINK1 KO mice were infected with IAV to reveal the role of mitophagy in viral infection. In IAV-infected mice, Tollip deficiency enhanced lung mitophagy (more PINK1 and BNIP3L, but less p62), and decreased release of mtDNA. Furthermore, Tollip deficiency suppressed STING activation and the antiviral response (eg IFN-β and MX1), and increased viral load. In IAV-infected Tollip KO mice, 2'3'cGAMP activated STING and increased antiviral response coupled with less virus. PINK1-deficient mice increased lung release of mtDNA and augmented STING activation and antiviral responses. PINK1 deficiency in mTECs increased STING activation and significantly decreased the viral load. Our findings suggest that enhanced mitophagy due to Tollip deficiency reduces mtDNA release and STING activation during viral infection, resulting in decreased antiviral responses. Reduction of mitophagy and/or STING activation may open novel avenues for therapeutic intervention in human subjects with Tollip deficiency and viral infection.
Insights
Toll-interacting protein (Tollip) deficiency worsens viral infection by enhancing mitophagy, which reduces mitochondrial DNA release and STING activation, impairing antiviral responses.
Area of Science:
- Immunology
- Cell Biology
- Virology
Background:
- Toll-interacting protein (Tollip) regulates mitophagy, a process crucial for cellular health.
- Tollip deficiency is linked to increased susceptibility to viral infections, but the underlying mechanisms are not fully understood.
Purpose of the Study:
- To investigate the role of mitophagy, mitochondrial DNA (mtDNA) release, and stimulator of interferon genes (STING) signaling in Tollip-deficient mice infected with influenza A virus (IAV).
Main Methods:
- Wild-type and Tollip knockout mice were infected with IAV and treated with a STING agonist.
- PINK1 knockout cells and mice were used to assess the impact of mitophagy.
- Mitochondrial markers, mtDNA release, STING activation, and antiviral gene expression were analyzed.
Main Results:
- Tollip deficiency enhanced lung mitophagy and suppressed STING activation and antiviral responses, leading to increased viral load.
- STING agonist treatment partially restored antiviral responses in Tollip-deficient mice.
- PINK1 deficiency (impaired mitophagy) increased mtDNA release, augmented STING activation, and enhanced antiviral responses.
Conclusions:
- Enhanced mitophagy in Tollip deficiency impairs antiviral immunity by reducing mtDNA release and STING activation.
- Targeting mitophagy or STING signaling may offer therapeutic strategies for viral infections in Tollip-deficient individuals.

